Elon's Vision
  • Contacts
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Elon's Vision
No Result
View All Result
Home News

Trump, Dominion and the Weaponization of Defamation

by
May 11, 2023
in News
0
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

On this episode of Radio Rothbard, Ryan McMaken and Tho Bishop talk about recent court cases involving defamation claims, justifying libertarian skepticism of the entire concept. As Ryan noted in a recent Wire article, the Dominion lawsuit in particular, is a particularly chilling case for free speech, with a taxpayer-funded company effectively silencing public critics. This, along with the recent Trump verdict, are an illustration of the continuing escalating weaponization of the court system for political ends.

New Radio Rothbard mugs are now available at the Mises Store. Get yours at Mises.org/RothMug 

PROMO CODE: RothPod for 20% off

Recommended Reading

“The Dominion Lawsuit against Fox News is Part of the War against Free Speech” by Ryan McMaken.: Mises.org/RR_133_A

“The Alex Jones Verdict Shows the Danger of Defamation Laws” by Ryan McMaken: Mises.org/RR_133_B

“Lawsuits Are the Hitman of the State” by Brian Caplan Mises.org/RR_133_C

Be sure to follow Radio Rothbard at Mises.org/RadioRothbard.

Previous Post

Should Local Municipalities Default on Their Debts? Seems Like a Good Idea

Next Post

Getting started with Kubernetes Observability with Prometheus and Grafana

Next Post
Getting started with Kubernetes Observability with Prometheus and Grafana

Getting started with Kubernetes Observability with Prometheus and Grafana

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest

Jay Bhattacharya on Public Health

October 12, 2021

Microsoft Planner vs Trello: Which Project Management Tool is Better?

May 24, 2023

An update on the National Nature Assessment

April 23, 2025

That Bangladesh Mask Study!

December 1, 2021
Friday Feature: Scholé Center for Innovative Education

Friday Feature: Scholé Center for Innovative Education

0

0

0

0
Friday Feature: Scholé Center for Innovative Education

Friday Feature: Scholé Center for Innovative Education

November 14, 2025

Is Your Business on the Nice List This Christmas?

November 14, 2025
A Tale of Two Cannabinoids: Congress’s Protectionist Pivot and Policy Dissonance

A Tale of Two Cannabinoids: Congress’s Protectionist Pivot and Policy Dissonance

November 14, 2025
Experts say there is “nothing to fear” from Employment Rights Bill as employers back fairer workplace reforms

Experts say there is “nothing to fear” from Employment Rights Bill as employers back fairer workplace reforms

November 14, 2025

Recent News

Friday Feature: Scholé Center for Innovative Education

Friday Feature: Scholé Center for Innovative Education

November 14, 2025

Is Your Business on the Nice List This Christmas?

November 14, 2025
A Tale of Two Cannabinoids: Congress’s Protectionist Pivot and Policy Dissonance

A Tale of Two Cannabinoids: Congress’s Protectionist Pivot and Policy Dissonance

November 14, 2025
Experts say there is “nothing to fear” from Employment Rights Bill as employers back fairer workplace reforms

Experts say there is “nothing to fear” from Employment Rights Bill as employers back fairer workplace reforms

November 14, 2025

Disclaimer: ElonsVision.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • Contacts
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 ElonsVision. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 ElonsVision. All Rights Reserved.